For instance, KRAS/NRAS mutations are particularly associated with brain and bone metastases, whereas PD‐L1 expression and TP53 mutations may influence metastasis to other organs in NSCLC.287, 312. The gene discussed is CD274; the disease is non-small cell lung carcinoma.